The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Interim safety analysis of a compassionate-use program (CUP) and early-access program (EAP) providing cabazitaxel (Cbz) plus prednisone (P) to patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel.
Zafar I. Malik
Honoraria - Astellas Pharma; AstraZeneca; GlaxoSmithKline; Janssen; Novartis; Pfizer; Sanofi
Giuseppe Di Lorenzo
No relevant relationships to disclose
Mert Basaran
No relevant relationships to disclose
Alexandros Ardavanis
Employment or Leadership Position - 1st Dpt of Medical Oncology Saint Savas Hospital, Athens, Greece
Honoraria - Novartis; Sanofi
Phillip Parente
Consultant or Advisory Role - Sanofi
Wito de Schultz
No relevant relationships to disclose
Fred Saad
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Research Funding - Sanofi
Inge van Oort
Honoraria - Sanofi
Winald R. Gerritsen
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Luis M. Antón Aparicio
Employment or Leadership Position - Complejo Hospitalario Universitario de A Coruña
Geoffrey Matus
No relevant relationships to disclose
Simon Hitier
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Axel Heidenreich
Consultant or Advisory Role - Amgen; Astellas Pharma; Janssen; Pfizer; Sanofi ; Takeda
Honoraria - Astellas Pharma; Bayer; Ipsen; Janssen; Sanofi ; Takeda
Research Funding - Astellas Pharma; Sanofi
Amit Bahl
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Research Funding - Sanofi